1/Today published in @JACCJournals is the 1st global consensus document on IVUS use for lower ext arterial & venous revasc. This document involved >40 international multidisciplinary experts in vascular disease & was led by a 12 person steering committee. https://t.co/Hzridqneb4

9/ In summary: • Burden of CMRFs among US adults with HTN has ⬆️ overall. • Concurrent DM + HL now affects >1 in 5 with HTN. • Only ~25% of adults with HTN, DM, and HL have all 3 conditions controlled—a figure unchanged for more than a decade.

1/ In lieu of 🦃, super excited to share our work on the prevalence, treatment, and control of cardiometabolic risk factors (CMRFs) among US adults with hypertension—now out in @JACCJournals! https://t.co/PheGg4V5fo

11/ Deeply grateful to my incredible mentor @EricSecemskyMD, unwavering supporters @rkwadhera @pnatarajanmd @somijemmacho, and wonderful collaborators @emilybcrawford @AKrawisz @spjuraschek @jenniferlcluett @hokyoulee @HyeonChangKim1 for making this project so fun and rewarding!

@EricSecemskyMD @rkwadhera @pnatarajanmd @somijemmacho @emilybcrawford @AKrawisz @spjuraschek @jenniferlcluett @hokyoulee @HyeonChangKim1 12/ Huge thanks as well to @JACCJournals, @hmkyale, and #YuanLu for helping this paper shine! @smithBIDMC @bidmccvi

Need the latest U.S. hypertension management stats? Or a break from 🦃🍗grease? Look no further—led by @HHLeeMD @EricSecemskyMD, we examined prevalenxe, trtment, and ctrl of cardiometabolic risk factors among adults with HTN @SmithBIDMC x @MassGenBrigham cc @CouncilonHTN

Excited to finally collaborate with long-time friends / colleagues @rkwadhera @EricSecemskyMD https://t.co/FHQLfiD5NO @JACCJournals @HHLeeMD @emilybcrawford @AKrawisz @somijemmacho @spjuraschek @jenniferlcluett @hokyoulee @HyeonChangKim1

For all those interested in cardiovascular research, please consider applying for a Sarnoff fellowship. @SmithBIDMC has been a frequent host and it’s been a wonderful experience. @frank_medina_ @AishRaja94 @BIDMCVFellows @BIDMChealth @SarnoffCardio @rwyeh @rkwadhera @DocStrom

This month, the Smith Center celebrated its 10 year anniversary. The past decade has been filled with impactful research, incredible learning, and community. Many thanks to our team - Here's to the next 10 years! https://t.co/0K64yY85fa

The VIVA Foundation team is honored to take on the CARVE meeting. Registration for CARVE 2026 is now open, and we invite you to join us in Snowmass for a high-quality program designed to support clinical excellence and professional connection. Learn more:

For all those interested in cardiovascular research, please consider applying for a Sarnoff fellowship. @SmithBIDMC has been a frequent host and it’s been a wonderful experience. @frank_medina_ @AishRaja94 @BIDMCVFellows @BIDMChealth @SarnoffCardio @rwyeh @rkwadhera @DocStrom

Andrassy, @EricSecemskyMD, and @gkorosoglou present a striking #ImagesInVascMed case of distal aortic stenosis—missed on cross-sectional MR angiography but revealed by invasive angiography and hemodynamic assessment. 🔗 https://t.co/EuZuoeqPoI #PAD

📢 By 2023, nearly 50% of CLTI revascularizations occurred in ambulatory centers ✅ Lower death/amputation risk vs hospitals ➡️ Reflects careful patient selection for ambulatory treatment New in @JACCJournals from @JMKimMD @EricSecemskyMD et al https://t.co/wkBg4rriO8 #PAD #CLTI

🚨 Published in @ehj_ed: The final analysis of the SAFE-PAD study confirms no long-term mortality risk with paclitaxel-coated devices for PAD. A landmark moment built on years of rigorous work by the Smith Center team👏 https://t.co/b1U1Pa9M7k #PAD #CardioTwitter #OutcomesResearch

Excited to see our home BP results in press! Note no change in AOBP vs changes in self-monitored BP. We observed med intensification and de-intensification in response to the home BPs...makes you wonder about those getting less treatment based on home... https://t.co/cuWf84NnaR

#VEITH2025: Eric Secemsky runs through meta-analytic data on the use of atherectomy in PAD, from a recently published review. @VEITHsymposium